BOSTON, Aug. 25 David J. Dykeman, intellectual property and technology shareholder in the Boston office of the international law firm Greenberg Traurig, LLP, was appointed to serve on the Massachusetts Life Sciences Collaborative's (MLSC) Research, Innovation and Commercialization Task Force.
Advertisement
The task force includes leading CEOs, academics, and venture capitalists in the life sciences and provides strategic guidance on issues related to life sciences innovation in Massachusetts. Dykeman is the only patent attorney on the task force.
Advertisement
"I am honored to be included in this important life sciences task force," said Dykeman. "The task force's efforts will help ensure that Massachusetts maintains and builds upon its preeminence in life sciences research, development and commercialization."
The MLSC seeks to create a cross-sector collaboration that can both sustain dialogue among life sciences leaders in academia, industry and government and also develop a comprehensive, integrated strategy to grow the life sciences mega-cluster in Massachusetts. The MLSC was founded by support from The Boston Foundation, the University of Massachusetts, Harvard University, MIT and the Massachusetts Technology Collaborative's John Adams Innovation Institute.
"The MLSC is pleased to welcome patent attorney David Dykeman to the Research, Innovation and Commercialization Task Force," said Glen A. Comiso, Director of eHealth and Life Sciences for the Massachusetts Technology Collaborative. "David's experience protecting the innovations of early stage life science and medical device companies will be a valuable addition."
"We are excited by David's involvement with the MLSC's task force," said Gary R. Greenberg, Co-Managing Shareholder of the Boston office. "This opportunity will enable David to expand his already extensive knowledge of the life sciences and continue to provide clients with a superior level of service."
Dykeman is a registered patent attorney with over 13 years of experience in patent and intellectual property law. He focuses his practice on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in medical devices, nanotechnology, information technology and life sciences. Dykeman is on the board of directors of Massachusetts Medical Device Industry Council (MassMEDIC), is a contributing editor to the Journal of BioLaw & Business, and is a frequent conference speaker and published author on intellectual property law.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, full-service law firm with approximately 1750 attorneys serving clients from more than 30 offices in the United States, Europe and Asia. For additional information, please visit the firm's Web site at www.gtlaw.com.
SOURCE Greenberg Traurig, LLP
